BQ1

Bedaquiline

Find entries where: BQ1

is present as a standalone ligand in 6 entries

Find related ligands:

Chemical Component Summary
Name	Bedaquiline
Identifiers	(1R,2S)-1-(6-bromanyl-2-methoxy-quinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenyl-butan-2-ol
Formula	C₃₂ H₃₁ Br N₂ O₂
Molecular Weight	555.50
Type	NON-POLYMER
Isomeric SMILES	CN(C)CC[C@@](c1cccc2c1cccc2)([C@H](c3ccccc3)c4cc5cc(ccc5nc4OC)Br)O
InChI	InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1
InChIKey	QUIJNHUBAXPXFS-XLJNKUFUSA-N

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	2
Bond Count	72
Aromatic Bond Count	28

Drug Info: DrugBank

DrugBank ID	DB08903
Name	Bedaquiline
Groups	approved
Description	Bedaquiline is a bactericidal antimycobacterial drug. Chemically it is a diarylquinoline. FDA approved on December 28, 2012.
Synonyms	Bédaquiline Bedaquiline fumarate 1-(6-Bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol Bedaquiline Bedaquilinum Bedaquilina
Brand Names	Sirturo
Indication	Bedaquiline is indicated as part of combination therapy in adults (≥ 18 years) with pulmonary multi-drug resistant tuberculosis (MDR-TB).
Categories	Anti-Bacterial Agents Anti-Infective Agents Antiinfectives for Systemic Use Antimycobacterials Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates Diarylquinoline Antimycobacterial Drugs for Treatment of Tuberculosis Heterocyclic Compounds, Fused-Ring Moderate Risk QTc-Prolonging Agents Mycobacterium tuberculosis QTc Prolonging Agents Quinolines
ATC-Code	J04AK05
CAS number	843663-66-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
ATP synthase subunit c	MDPTIAAGALIGGGLIMAGGAIGAGIGDGVAGNALISGVARQPEAQGRLF...	unknown	inhibitor
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682